Seung Taek Lim

486 total citations
35 papers, 324 citations indexed

About

Seung Taek Lim is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Seung Taek Lim has authored 35 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 8 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Seung Taek Lim's work include Breast Cancer Treatment Studies (6 papers), Thyroid and Parathyroid Surgery (5 papers) and HER2/EGFR in Cancer Research (5 papers). Seung Taek Lim is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Thyroid and Parathyroid Surgery (5 papers) and HER2/EGFR in Cancer Research (5 papers). Seung Taek Lim collaborates with scholars based in South Korea, United States and Switzerland. Seung Taek Lim's co-authors include Young Jin Suh, Ye Won Jeon, Hyun Joo Choi, Byung Kyun Ko, Heung Kyu Park, Se Young Kim, Byung-In Moon, Jong Han Yu, Seok Jin Nam and Sang Joon Shin and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Seung Taek Lim

33 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seung Taek Lim South Korea 12 127 101 96 59 55 35 324
Toshiharu Maeda Japan 10 106 0.8× 135 1.3× 153 1.6× 94 1.6× 76 1.4× 24 394
Tae Jung Kwon South Korea 11 76 0.6× 155 1.5× 54 0.6× 36 0.6× 47 0.9× 28 430
Linde M. Morsink Netherlands 11 141 1.1× 57 0.6× 124 1.3× 39 0.7× 17 0.3× 24 483
Shinichi Asaka Japan 12 161 1.3× 109 1.1× 48 0.5× 99 1.7× 96 1.7× 58 462
Takefumi Yoshida Japan 11 212 1.7× 124 1.2× 30 0.3× 70 1.2× 97 1.8× 38 394
Nitya Nathwani United States 12 186 1.5× 90 0.9× 65 0.7× 49 0.8× 39 0.7× 37 528
Stephen I. Fisher United States 12 84 0.7× 132 1.3× 58 0.6× 80 1.4× 61 1.1× 23 433
Virendra Patil India 11 92 0.7× 152 1.5× 183 1.9× 19 0.3× 52 0.9× 60 395
Jisu Oh South Korea 10 52 0.4× 103 1.0× 93 1.0× 29 0.5× 110 2.0× 24 429
Tetsuya Urasaki Japan 12 205 1.6× 99 1.0× 55 0.6× 26 0.4× 50 0.9× 53 416

Countries citing papers authored by Seung Taek Lim

Since Specialization
Citations

This map shows the geographic impact of Seung Taek Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seung Taek Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seung Taek Lim more than expected).

Fields of papers citing papers by Seung Taek Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seung Taek Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seung Taek Lim. The network helps show where Seung Taek Lim may publish in the future.

Co-authorship network of co-authors of Seung Taek Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Seung Taek Lim. A scholar is included among the top collaborators of Seung Taek Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seung Taek Lim. Seung Taek Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Seung Taek, et al.. (2025). Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer. Scientific Reports. 15(1). 920–920. 1 indexed citations
3.
Lim, Seung Taek, et al.. (2024). Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients. International Journal of Molecular Sciences. 25(8). 4561–4561. 3 indexed citations
4.
Lim, Seung Taek, Hye Ryun Kim, Eun Joo Kang, et al.. (2024). Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study. Oral Oncology. 151. 106739–106739. 2 indexed citations
6.
Kim, Yundeok, Tae‐Hwa Go, Jii Bum Lee, et al.. (2021). Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia. The Korean Journal of Internal Medicine. 36(6). 1450–1458. 10 indexed citations
9.
Nam, Seok Jin, Soo Jung Lee, Jin Hyang Jung, et al.. (2020). Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Breast Cancer. 23(3). 259–259. 4 indexed citations
10.
Hyun, Shin Young, et al.. (2019). Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 19(11). 735–743.e2. 6 indexed citations
11.
Jeon, Ye Won, et al.. (2019). Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy. Annals of Surgical Oncology. 26(9). 2952–2958. 51 indexed citations
12.
Lim, Seung Taek, Chan Heun Park, Sung Yong Kim, et al.. (2018). The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer. PLoS ONE. 13(5). e0197523–e0197523. 7 indexed citations
14.
Lim, Seung Taek, Jung Eun Choi, Sei Joong Kim, et al.. (2016). Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population. Breast Cancer Research and Treatment. 156(3). 473–483. 11 indexed citations
15.
Lee, Se Kyung, Jeong Eon Lee, Hyung Seok Park, et al.. (2016). Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database. Medicine. 95(16). e3299–e3299. 14 indexed citations
16.
Lim, Seung Taek, Ye Won Jeon, & Young Jin Suh. (2016). The Prognostic Values of Preoperative Tumor Volume and Tumor Diameter in T1N0 Papillary Thyroid Cancer. Cancer Research and Treatment. 49(4). 890–897. 12 indexed citations
17.
Lim, Seung Taek, Ye Won Jeon, & Young Jin Suh. (2015). Correlation Between Surgical Extent and Prognosis in Node‐Negative, Early‐Stage Papillary Thyroid Carcinoma Originating in the Isthmus. World Journal of Surgery. 40(2). 344–349. 27 indexed citations
18.
Lim, Seung Taek, Jong Han Yu, Heung Kyu Park, et al.. (2014). A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population. World Journal of Surgical Oncology. 12(1). 56–56. 21 indexed citations
19.
Kim, Gun Min, Young Sam Kim, Young Ae Kang, et al.. (2012). Efficacy and Toxicity of Belotecan for Relapsed or Refractory Small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 7(4). 731–736. 20 indexed citations
20.
Lee, Sang Woo, et al.. (2003). [A case of gastric ulcer induced by Helicobacter heilmannii-like organism].. PubMed. 42(1). 63–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026